1. Wieck A, Haddad PM. Antipsychotic-induced hyperprolactinaemia in women: pathophysiology, severity and consequences. Selective literature review. Br J Psychiatry 2003;182:199-204. PMID:
12611781.
2. Checkley S. Neuroendocrine effects of psychotropic drugs. Baillieres Clin Endocrinol Metab 1991;5:15-33. PMID:
1674856.
3. Hall MJ. Breast tenderness and enlargement induced by sertraline. Am J Psychiatry 1994;151:1395-1396. PMID:
8067502.
4. Peterson MC. Reversible galactorrhea and prolactin elevation related to fluoxetine use. Mayo Clin Proc 2001;76:215-216. PMID:
11213313.
5. Spigset O, Mjorndal T. The effect of fluvoxamine on serum prolactin and serum sodium concentrations: relation to platelet 5-HT2A receptor status. J Clin Psychopharmacol 1997;17:292-297. PMID:
9241009.
6. Spitzer RL, Williams JB, Gibbon M, First MB. The structured clinical interview for DSM-III-R (SCID). I: history, rationale, and description. Arch Gen Psychiatry 1992;49:624-629. PMID:
1637252.
7. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967;6:278-296. PMID:
6080235.
8. Yi JS, Bae SO, Ahn YM, Park DB, Noh KS, Shin HK, et al. Validity and reliability of the Korean version of the Hamilton Depression Rating Scale (K-HDRS). J Korean Neuropsychiatr Assoc 2005;44:456-465.
9. Beck AT. Depression: Clinical, Experimental, and Theoretical Aspects. 1967,NewYork: Harper & Row.
10. Lee YH, Song JY. A study of the reliability and the validity of the BDI, SDS, and MMPI-D Scales. Korean J Clin Psychol 1991;10:98-113.
11. Damsa C, Bumb A, Bianchi-Demicheli F, Vidailhet P, Sterck R, Andreoli A, et al. "Dopamine-dependent" side effects of selective serotonin reuptake inhibitors: a clinical review. J Clin Psychiatry 2004;65:1064-1068. PMID:
15323590.
12. Seifritz E, Baumann P, Müller MJ, Annen O, Amey M, Hemmeter U, et al. Neuroendocrine effects of a 20-mg citalopram infusion in healthy males. A placebo-controlled evaluation of citalopram as 5-HT function probe. Neuropsychopharmacology 1996;14:253-263. PMID:
8924193.
13. Nicholas L, Dawkins K, Golden RN. Psychoneuroendocrinology of depression. Prolactin. Psychiatr Clin North Am 1998;21:341-358. PMID:
9670230.
14. Arya DK. Extrapyramidal symptoms with selective serotonin reuptake inhibitors. Br J Psychiatry 1994;165:728-733. PMID:
7881774.
15. Meltzer HY, Young M, Metz J Fang VS, Schyve PM, Arora RC. Extrapyramidal side effects and increased serum prolactin following fluoxetine, a new antideptressant. J Neural Transm 1979;45:165-175. PMID:
313977.
16. Kim SW, Dysken MW. Potential antidopaminergic effects of serotonin reuptake inhibitors. J Clin Psychiatry 1991;52:42PMID:
1988420.
17. Kiss J, Halász B. Synaptic connections between serotoninergic axon terminals and tyrosine hydroxylase-immunoreactive neurons in the arcuate nucleus of the rat hypothalamus. A combination of electron microscopic autoradiography and immunocytochemistry. Brain Res 1986;364:284-294. PMID:
2868780.
18. Mirkes SJ, Bethea CL. Oestrogen, progesterone and serotonin converge on GABAergic neurones in the monkey hypothalamus. J Neuroendocrinol 2001;13:182-192. PMID:
11168844.
19. Gulsun M, Evrensel A, Verim S. Galactorrhea during escitalopram treatment: a case report. Bull Clin Psychopharmacol 2006;16:39-41.
20. Gulsun M, Algul A, Semiz UB, Ates MA, Doruk A, Ebrinc S, et al. A case with euprolactinemic galactorrhea induced by escitalopram. Int J Psychiatry Med 2007;37:275-278. PMID:
18314855.